BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3958271)

  • 1. How well do physicians recognize melanoma and other problem lesions?
    Cassileth BR; Clark WH; Lusk EJ; Frederick BE; Thompson CJ; Walsh WP
    J Am Acad Dermatol; 1986 Apr; 14(4):555-60. PubMed ID: 3958271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dermatologists' and nondermatologists' diagnostic accuracy for malignant melanoma.
    Corbo MD; Vender R; Wismer J
    J Cutan Med Surg; 2012; 16(4):272-80. PubMed ID: 22784521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France].
    Grange F; Hédelin G; Halna JM; Grall JC; Kirstetter H; Guillaume JC; Michel C
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):956-61. PubMed ID: 16446636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight of decision-making impairs clinical assessment of melanocytic lesions.
    Gächter T; Mühleisen B; Schärer L; Dummer R; Burg G; Hofbauer GF
    J Cutan Med Surg; 2007; 11(1):9-18. PubMed ID: 17274934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer algorithms show potential for improving dermatologists' accuracy to diagnose cutaneous melanoma: Results of the International Skin Imaging Collaboration 2017.
    Marchetti MA; Liopyris K; Dusza SW; Codella NCF; Gutman DA; Helba B; Kalloo A; Halpern AC;
    J Am Acad Dermatol; 2020 Mar; 82(3):622-627. PubMed ID: 31306724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Survey: How Do Transplant Dermatologists Monitor Organ Transplant Recipients With Nevi?
    Özcan D; Seçkin D; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):198-202. PubMed ID: 29528027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
    Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
    Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma trainer using simulated back skin: an innovative design.
    MacGregor CA; O'Donnell MK; Haley AC; Martini M; Robinson JK; Vozenilek JA
    Simul Healthc; 2012 Aug; 7(4):251-4. PubMed ID: 22678225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of pigmented lesions.
    Schaffer JV; Bolognia JL
    Clin Plast Surg; 2000 Jul; 27(3):391-408, viii. PubMed ID: 10941560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between melanocytic nevi and malignant melanoma.
    Friedman RJ; Rigel DS; Heilman ER
    Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer.
    Gerbert B; Maurer T; Berger T; Pantilat S; McPhee SJ; Wolff M; Bronstone A; Caspers N
    Arch Dermatol; 1996 Sep; 132(9):1030-8. PubMed ID: 8795541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rational clinical examination. Does this patient have a mole or a melanoma?
    Whited JD; Grichnik JM
    JAMA; 1998 Mar; 279(9):696-701. PubMed ID: 9496989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who removes pigmented skin lesions?
    Marks R; Jolley D; McCormack C; Dorevitch AP
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):721-6. PubMed ID: 9146533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant melanocytic lesions in infancy, childhood, and adolescence.
    Hoss DM; Grant-Kels JM
    Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic yield of histologic examination of seborrheic keratoses.
    Eads TJ; Hood AF; Chuang TY; Faust HB; Farmer ER
    Arch Dermatol; 1997 Nov; 133(11):1417-20. PubMed ID: 9371026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions.
    Brochez L; Verhaeghe E; Bleyen L; Naeyaert JM
    J Am Acad Dermatol; 2001 Jun; 44(6):979-86. PubMed ID: 11369910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma.
    Keefe M; Dick DC; Wakeel RA
    Clin Exp Dermatol; 1990 May; 15(3):167-71. PubMed ID: 2142028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.